Fedratinib hydrochloride hydrate, CAS [[1374744-69-0]]

Product Overview

• Article Name: Fedratinib hydrochloride hydrate, CAS [[1374744-69-0]]
• Biozol Catalog Number: BYT-ORB1298242
• Supplier Catalog Number: orb1298242
• Alternative Catalog Number: BYT-ORB1298242-1, BYT-ORB1298242-10, BYT-ORB1298242-100, BYT-ORB1298242-200, BYT-ORB1298242-25, BYT-ORB1298242-5, BYT-ORB1298242-50
• Manufacturer: Biorbyt
• Category: Biochemikalien
• Alternative Names: anti-proliferation, Apoptosis, anti-cancer, Inhibitor, FLT3, Fedratinib hydrochloride, Fedratinib hydrochloride Hydrate, Fedratinib hydrochloride hydrate, orally, inhibit, JAK2, JAK, JAK2V617F, JAK2 (V617F), Janus kinase, myeloproliferative, phosphorylation, RET, SAR 302503 hydrochloride, SAR 302503 hydrochloride hydrate, SAR 302503 hydrochloride Hydrate, TG-101348 hydrochloride, TG-101348 hydrochloride hydrate, TG-101348 hydrochloride Hydrate, STAT5

Product Description

Fedratinib hydrochloride hydrate is an orally bioavailable, selective, and ATP-competitive small molecule inhibitor of JAK2. It is widely used in preclinical research to investigate myeloproliferative neoplasms, demonstrating activity in both cellular assays and animal models of disease.

Product Properties

• Molecular Weight: 615.61
• Purity: 99.87% (May vary between batches)
• CAS Number: [1374744-69-0]
• Formula: C27H40Cl2N6O4S
• Target: JAK,Apoptosis

Application Notes

• Application Notes: Solubility: DMSO:120 mg/mL (194.93 mM),10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (6.5 mM),H2O:97 mg/mL (157.57 mM)